Literature DB >> 20965177

Hip2 interacts with cyclin B1 and promotes its degradation through the ubiquitin proteasome pathway.

Yoonhee Bae1, Dongwon Choi, Hyangshuk Rhim, Seongman Kang.   

Abstract

Hip2, a ubiquitin conjugating enzyme, is involved in the suppression of cell death. The present study revealed that Hip2 regulates the stability of the apoptotic and cell cycle regulator cyclin B1. Hip2 was found to interact with cyclin B1 to promote its degradation through the ubiquitin proteasome pathway. As a result, Hip2 significantly blocked cell death induced by the cyclin B1 protein, suggesting that Hip2 is involved in the regulation of cyclin B1-mediated cell death.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965177     DOI: 10.1016/j.febslet.2010.10.016

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Hip2 ubiquitin-conjugating enzyme has a role in UV-induced G1/S arrest and re-entry.

Authors:  Nan Hee Hong; Yeong Jin Tak; Hyangshuk Rhim; Seongman Kang
Journal:  Genes Genomics       Date:  2018-09-27       Impact factor: 1.839

2.  C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response.

Authors:  Rebecca L Ambrose; Yu Chih Liu; Timothy E Adams; Andrew G D Bean; Cameron R Stewart
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

3.  Ataxin-1 is involved in tumorigenesis of cervical cancer cells via the EGFR-RAS-MAPK signaling pathway.

Authors:  A-Ram Kang; Hyoung-Tae An; Jesang Ko; Eui-Ju Choi; Seongman Kang
Journal:  Oncotarget       Date:  2017-10-10

4.  Reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis.

Authors:  Jugang Wu; Baoxing Tian; Jianjun Yang; Haizhong Huo; Zhicheng Song; Jiwei Yu; Yan Gu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.